Published work

• Cuddy, Emily and Janet Currie. 2026. “Rules vs. Discretion: Treatment of Mental Illness in U.S. Adolescents.” Journal of Political Economy, 134(1): 478-522.

• Cuddy, Emily, Yun Peng Lu, and David B. Ridley. 2023. “FDA Global Drug Inspections: Surveillance of Manufacturing Establishments Remains Well Below Pre–COVID–19 Levels.” Health Affairs, 42(12): 1758–1766.

• Cuddy, Emily and Janet Currie. 2020. “Treatment of Mental Illness in American Adolescents Varies Widely Within and Across Areas.” Proceedings of the National Academy of Sciences, 117(39): 24039–24046.

Working Papers

• Competition and Collusion in the US Generic Drug Market

• “Teen Suicide and the Outcomes of Surviving Peers” with Janet Currie, Elisa Jácome, and Lucy Manly

WorKS IN PROGRESS

• “Quality in the Generic Drug Market” with Molly Schnell

• “Labor Market Impacts of Mental Health” with Ronja Helénsdotter and Elisa Jácome

• “Regulatory Incentives and Industry Capture: The Case of the FDA” with Evgenii Fadeev and David Ridley

• “The Long-Run Effects of Psychiatric Hospital Closures” with Ronja Helénsdotter, Elisa Jácome, and Hellary Zhang

• “Mental Health Spillovers in Families” with Mike Cassidy and Janet Currie

Other writing

• Cuddy, Emily, Rob Porter, Amanda Starc, and Tom Wollman. Entry Barriers, Personal Relationships, and Cartel Formation. Cartels Diagnosed: New Insights on Collusion, edited by Joseph E. Harrington Jr. and Maarten Pieter Schinkel, Cambridge University Press, 2025, pp. 12-43.